Header Logo

Robert C Rathbun

TitleProf & Chair
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentPharmacy Clinical & Admin Sci
AddressCPB 219
1110 N Stonewall Ave
Oklahoma City OK 73117
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Rathbun RC, Lewis MM, Yuet WC, Woo S, Miller JL, Skrepnek GH. The Medication Possession Ratio as a Predictor of Longitudinal HIV-1 Viral Suppression. Ann Pharmacother. 2023 Mar 22; 10600280231156624. PMID: 36946586.
      Citations: 1     Fields:    Translation:HumansCells
    2. Rathbun RC, Durham SH, Farmer KC, Zuckerman AD, Badowski ME. Evaluation of human immunodeficiency virus curricular content in schools of pharmacy in the United States. Curr Pharm Teach Learn. 2020 08; 12(8):910-917. PMID: 32564992.
      Citations: 6     Fields:    Translation:HumansCells
    3. Pham T, Rathbun RC, Keast S, Nesser N, Farmer K, Skrepnek G. National estimates of case-mix, mortality, and economic outcomes among inpatient HIV/AIDS mono-infection and hepatitis C co-infection cases in the US. J Eval Clin Pract. 2019 Oct; 25(5):806-821. PMID: 30485617.
      Citations: 1     Fields:    Translation:Humans
    4. Pham TT, Keast SL, Farmer KC, Thompson DM, Rathbun RC, Nesser NJ, Holderread BP, Skrepnek GH. Sustained Virologic Response and Costs Associated with Direct-Acting Antivirals for Chronic Hepatitis C Infection in Oklahoma Medicaid. J Manag Care Spec Pharm. 2018 Jul; 24(7):664-676. PMID: 29952711.
      Citations: 5     Fields:    Translation:HumansCells
    5. Durham SH, Badowski ME, Liedtke MD, Rathbun RC, Pecora Fulco P. Acute Care Management of the HIV-Infected Patient: A Report from the HIV Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy. 2017 May; 37(5):611-629. PMID: 28273373.
      Citations: 3     Fields:    Translation:Humans
    6. Liedtke MD, Tomlin CR, Skrepnek GH, Farmer KC, Johnson PN, Rathbun RC. HIV Pharmacist's Impact on Inpatient Antiretroviral Errors. HIV Med. 2016 11; 17(10):717-723. PMID: 27038405.
      Citations: 7     Fields:    Translation:Humans
    7. Scalese MJ, Herring HR, Rathbun RC, Skrepnek GH, Ripley TL. Propofol-associated QTc prolongation. Ther Adv Drug Saf. 2016 Jun; 7(3):68-78. PMID: 27298717.
      Citations: 5     
    8. Miller MM, Liedtke MD, Lockhart SM, Rathbun RC. The role of dolutegravir in the management of HIV infection. Infect Drug Resist. 2015; 8:19-29. PMID: 25733917.
      Citations: 7     
    9. Liedtke MD, Tomlin CR, Lockhart SM, Miller MM, Rathbun RC. Long-term efficacy and safety of raltegravir in the management of HIV infection. Infect Drug Resist. 2014; 7:73-84. PMID: 24672249.
      Citations: 12     
    10. Kleyn TJ, Liedtke MD, Harrison DL, Lockhart SM, Salvaggio MR, Ripley TL, Rathbun RC. Incidence of transmitted antiretroviral drug resistance in treatment-naive HIV-1-infected persons in a large South Central United States clinic. Ann Pharmacother. 2014 Apr; 48(4):470-5. PMID: 24473489.
      Citations: 6     Fields:    Translation:HumansCells
    11. Ripley TL, Adamson PB, Hennebry TA, Van Tuyl JS, Harrison DL, Rathbun RC. Collaborative practice model between cardiologists and clinical pharmacists for management of patients with cardiovascular disease in an outpatient clinic. Ann Pharmacother. 2014 Mar; 48(3):412-9. PMID: 24321852.
      Citations: 3     Fields:    Translation:Humans
    12. Rathbun RC, Lockhart SM, Miller MM, Liedtke MD. Dolutegravir, a second-generation integrase inhibitor for the treatment of HIV-1 infection. Ann Pharmacother. 2014 Mar; 48(3):395-403. PMID: 24259658.
      Citations: 10     Fields:    Translation:Humans
    13. Rathbun RC. HIV consensus guideline recommends antiretroviral treatment regardless of CD4 count, new regimens and possible regimen change for chronic low level viraemia. Evid Based Med. 2013 Aug; 18(4):149-50. PMID: 23154674.
      Citations:    Fields:    Translation:Humans
    14. Liedtke MD, Vanguri A, Rathbun RC. A probable interaction between warfarin and the antiretroviral TRIO study regimen. Ann Pharmacother. 2012 Nov; 46(11):e34. PMID: 23115227.
      Citations: 4     Fields:    Translation:Humans
    15. Ripley TL, Hennebry TA, Sanders TN, Harrison D, Rathbun RC. Impact of a clinical pharmacist on a cardiovascular surrogate endpoint: a pilot study. Pharm Pract (Granada). 2012 Jul; 10(3):173-9. PMID: 24155834.
      Citations:    
    16. Rathbun RC, Hester EK, Arnold LM, Chung AM, Dunn SP, Harinstein LM, Leber M, Murphy JA, Schonder KS, Wilhelm SM, Smilie KB. Importance of direct patient care in advanced pharmacy practice experiences. Pharmacotherapy. 2012 Apr; 32(4):e88-97. PMID: 22461125.
      Citations: 13     Fields:    Translation:Humans
    17. Rathbun RC, Liedtke MD. Antiretroviral drug interactions: overview of interactions involving new and investigational agents and the role of therapeutic drug monitoring for management. Pharmaceutics. 2011 Oct 21; 3(4):745-81. PMID: 24309307.
      Citations: 18     
    18. Liedtke MD, Rathbun RC. Drug interactions with antiretrovirals and warfarin. Expert Opin Drug Saf. 2010 Mar; 9(2):215-23. PMID: 20095918.
      Citations: 14     Fields:    Translation:HumansAnimals
    19. Rathbun CR, Liedtke MD, Blevins SM, Harrison D, Lockhart SM, Salvaggio M, Acosta EP. Electrocardiogram abnormalities with atazanavir and lopinavir/ritonavir. HIV Clin Trials. 2009 Sep-Oct; 10(5):328-36. PMID: 19906626.
      Citations: 10     Fields:    Translation:HumansCellsCTClinical Trials
    20. Liedtke MD, Rathbun RC. Warfarin-antiretroviral interactions. Ann Pharmacother. 2009 Feb; 43(2):322-8. PMID: 19196837.
      Citations: 17     Fields:    Translation:Humans
    21. Stephens JR, Rathbun RC, Lockhart SM, Bronze MS, Greenfield RA. Part XV. Antiretroviral therapy for human immunodeficiency virus infection. J Okla State Med Assoc. 2007 Nov; 100(11):417-24. PMID: 18183858.
      Citations:    Fields:    Translation:Humans
    22. Lockhart SM, Rathbun RC, Stephens JR, Baker DL, Drevets DA, Greenfield RA, Salvaggio MR, Vincent S. Cutaneous reactions with tenofovir disoproxil fumarate: a report of nine cases. AIDS. 2007 Jun 19; 21(10):1370-3. PMID: 17545718.
      Citations: 7     Fields:    Translation:Humans
    23. Rathbun RC, Farmer KC, Lockhart SM, Stephens JR. Validity of a stage of change instrument in assessing medication adherence in indigent patients with HIV infection. Ann Pharmacother. 2007 Feb; 41(2):208-14. PMID: 17213294.
      Citations: 10     Fields:    Translation:Humans
    24. Rathbun RC, Lockhart SM, Stephens JR. Current HIV treatment guidelines--an overview. Curr Pharm Des. 2006; 12(9):1045-63. PMID: 16515485.
      Citations: 23     Fields:    Translation:Humans
    25. Rathbun RC, Farmer KC, Stephens JR, Lockhart SM. Impact of an adherence clinic on behavioral outcomes and virologic response in treatment of HIV infection: a prospective, randomized, controlled pilot study. Clin Ther. 2005 Feb; 27(2):199-209. PMID: 15811483.
      Citations: 39     Fields:    Translation:HumansCTClinical Trials
    26. Liedtke MD, Lockhart SM, Rathbun RC. Anticonvulsant and antiretroviral interactions. Ann Pharmacother. 2004 Mar; 38(3):482-9. PMID: 14970370.
      Citations: 8     Fields:    Translation:Humans
    27. Moomaw MD, Cornea P, Rathbun RC, Wendel KA. Review of antiviral therapy for herpes labialis, genital herpes and herpes zoster. Expert Rev Anti Infect Ther. 2003 Aug; 1(2):283-95. PMID: 15482124.
      Citations: 8     Fields:    Translation:HumansAnimals
    28. Rossi DR, Rathbun RC, Slater LN. Symptomatic orthostasis with extended-release nifedipine and protease inhibitors. Pharmacotherapy. 2002 Oct; 22(10):1312-6. PMID: 12389881.
      Citations: 3     Fields:    Translation:Humans
    29. Rathbun RC, Rossi DR. Low-dose ritonavir for protease inhibitor pharmacokinetic enhancement. Ann Pharmacother. 2002 Apr; 36(4):702-6. PMID: 11918523.
      Citations: 10     Fields:    Translation:Humans
    30. Hoffman HL, Rathbun RC. Review of the safety and efficacy of voriconazole. Expert Opin Investig Drugs. 2002 Mar; 11(3):409-29. PMID: 11866669.
      Citations: 27     Fields:    Translation:HumansAnimals
    31. Clay PG, Rathbun RC, Slater LN. Management protocol for abacavir-related hypersensitivity reaction. Ann Pharmacother. 2000 Feb; 34(2):247-9. PMID: 10676833.
      Citations: 2     Fields:    Translation:Humans
    32. Clay PG, Rathbun RC, Slater LN. Nevirapine, didanosine, and zidovudine for patients with HIV: the INCAS trial. Italy, Netherlands, Canada, and Australia. JAMA. 1999 Jan 13; 281(2):130; author reply 131. PMID: 9917107.
      Citations:    Fields:    Translation:Humans
    33. Mihm LB, Rathbun RC, Resman-Targoff BH. Hyperkalemia associated with high-dose trimethoprim-sulfamethoxazole in a patient with the acquired immunodeficiency syndrome. Pharmacotherapy. 1995 Nov-Dec; 15(6):793-7. PMID: 8602391.
      Citations: 2     Fields:    Translation:Humans
    34. Morrison YY, Rathbun RC. Hantavirus pulmonary syndrome: the Four Corners disease. Ann Pharmacother. 1995 Jan; 29(1):57-65. PMID: 7711347.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    35. Morrison YY, Rathbun RC, Huycke MM. Disseminated histoplasmosis mimicking Crohn's disease in a patient with the acquired immunodeficiency syndrome. Am J Gastroenterol. 1994 Aug; 89(8):1255-7. PMID: 8053447.
      Citations: 2     Fields:    Translation:Humans
    36. Rathbun RC. Surrogate markers for assessing treatment response in HIV disease. Ann Pharmacother. 1993 Apr; 27(4):450-5. PMID: 8097416.
      Citations: 2     Fields:    Translation:HumansCells
    37. Rathbun RC, Martin ES. Didanosine therapy in patients intolerant of or failing zidovudine therapy. Ann Pharmacother. 1992 Nov; 26(11):1347-51. PMID: 1362093.
      Citations: 1     Fields:    Translation:HumansCells
    38. Rathbun RC, Martin ES, Eaton VE, Matthew EB. Current and investigational therapies for AIDS-associated Mycobacterium avium complex disease. Clin Pharm. 1991 Apr; 10(4):280-91. PMID: 2032445.
      Citations: 2     Fields:    Translation:HumansCells
    39. Robertson DW, Lawson RR, Rathbun RC, Leander JD. Pharmacology of LY201409, a potent benzamide anticonvulsant. Epilepsia. 1988 Nov-Dec; 29(6):760-9. PMID: 3191892.
      Citations:    Fields:    Translation:Animals
    40. Leander JD, Rathbun RC, Zimmerman DM. Anticonvulsant effects of phencyclidine-like drugs: relation to N-methyl-D-aspartic acid antagonism. Brain Res. 1988 Jun 28; 454(1-2):368-72. PMID: 2841999.
      Citations: 12     Fields:    Translation:Animals
    41. Leander JD, Robertson DW, Clark CR, Lawson RR, Rathbun RC. Pharmacological effects of enantiomers of 4-amino-N-(alpha-methylbenzyl)benzamide, a chemically novel anticonvulsant. Epilepsia. 1988 Jan-Feb; 29(1):83-90. PMID: 3338426.
      Citations: 2     Fields:    Translation:Animals
    42. Robertson DW, Krushinski JH, Beedle EE, Leander JD, Wong DT, Rathbun RC. Structure-activity relationships of (arylalkyl)imidazole anticonvulsants: comparison of the (fluorenylalkyl)imidazoles with nafimidone and denzimol. J Med Chem. 1986 Sep; 29(9):1577-86. PMID: 3746810.
      Citations: 5     Fields:    Translation:Animals
    43. Rathbun RC, Kattau RW, Leander JD. Effects of mu- and kappa-opioid receptor agonists on urinary output in mice. Pharmacol Biochem Behav. 1983 Nov; 19(5):863-6. PMID: 6316374.
      Citations: 2     Fields:    Translation:Animals
    44. Wong DT, Rathbun RC, Bymaster FP, Lacefield WB. Enhanced binding of radioligands to receptors of gamma-aminobutyric acid and benzodiazepine by a new anticonvulsive agent, LY81067. Life Sci. 1983 Sep 05; 33(10):917-23. PMID: 6310287.
      Citations: 1     Fields:    Translation:Animals
    45. Slater IH, Rathbun RC, Kattau R. Role of 5-hydroxytryptaminergic and adrenergic mechanism in antagonism of reserpine-induced hypothermia in mice. J Pharm Pharmacol. 1979 Feb; 31(2):108-10. PMID: 33241.
      Citations: 3     Fields:    Translation:Animals
    46. Fuller RW, Rathbun RC, Parli CJ. Inhibition of drug metabolism by fluoxetine. Res Commun Chem Pathol Pharmacol. 1976 Feb; 13(2):353-6. PMID: 943818.
      Citations: 7     Fields:    Translation:Animals
    47. Owen JE, Rathbun RC. Effects of long, intermittent schedules on phenothiazine-induced avoidance loss. Psychopharmacologia. 1967; 12(1):24-33. PMID: 6081325.
      Citations:    Fields:    Translation:Animals
    48. Owen JE, Rathbun RC. Sustained changes of avoidance behavior after chronic nortriptyline administration. Psychopharmacologia. 1966; 9(2):137-54. PMID: 5983912.
      Citations: 2     Fields:    Translation:Animals
    49. RATHBUN RC, SLATER IH. AMITRIPTYLINE AND NORTRIPTYLINE AS ANTAGONISTS OF CENTRAL AND PERIPHERAL CHOLINERGIC ACTIVATION. Psychopharmacologia. 1963 Apr 16; 4:114-25. PMID: 14050417.
      Citations: 12     Fields:    Translation:Animals
    50. SLATER IH, RATHBUN RC, HENDERSON FG, NEUSS N. Pharmacological properties of recanescine, a new sedative alkaloid from Rauwolfia canescens Linn. Proc Soc Exp Biol Med. 1955 Feb; 88(2):293-5. PMID: 14357418.
      Citations: 1     Fields:    Translation:Animals
    51. SHIDEMAN FE, RATHBUN RC, STONEMAN F. Inhibition of the renal tubular transport of p-aminohippurate (PAH) and phenolsulfonphthalein (PSP) as affected by acetate. Am J Physiol. 1952 Jul; 170(1):31-7. PMID: 12985860.
      Citations: 2     Fields:    
    52. RATHBUN RC, SHIDEMAN FE. A quantitative method for study of phenolsulfonphthalein (PSP) concentration by surviving renal slices. Proc Soc Exp Biol Med. 1951 Dec; 78(3):741-4. PMID: 14912014.
      Citations:    Fields:    Translation:Humans
    Rathbun's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (275)
    Explore
    _
    Co-Authors (10)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _